Hao Wang

Brief Introduction for Wang Hao

Research Area

Pathogenesis of psoriasis

Academic Resume

Dr. Hao Wang graduated from Xi'an Jiaotong University(XJTU) school of medicine in 2007 with PhD, and serve as the chief physician and doctoral supervisor for dermatology of the second affiliated hospital to XJTU now. Dr. Wang Hao has dedicated to the research on the pathogenesis and clinical therapy of psoriasis and participated in international and domestic multi-center clinical drug trials. His academic positions and honors are as follows.

National outstanding young and middle-aged scientific and technological worker of integrated traditional Chinese and Western medicine.

Member of the hair disease group of the CSD

Member of the infectious skin disease group of the CDA

Member of the Dermatology Branch of the Shaanxi Provincial Medical Doctor Association

First-instance expert of the National Natural Science Foundation of China

Research Projects

1. Experimental study of targeted delivery of siRNA to silence Livin gene in the treatment of malignant melanoma (NSFC, No. 30960349)

2. Livin is critical in keratinocyte proliferation and inflammatory responses under psoriasic microenvironment (NSFC, No. 81872529)

3. Study on the mechanism of action of Livin in psoriasis vulgaris and its clinical diagnostic value (Key Research and Development Programof Shaanxi, No.2018SF-007)

4. Clinical study of surgical operation combined with 5-FU and local microinjection of betamethasone in the treatment of keloid (Key Research and Development Programof Shaanxi, No. 2021SF-280)

Representative papers

1. Wang H, Tan SS, Wang XY, Liu DH, Yu CS, Bai ZL, He DL, Zhao J. Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells. Acta Pharmacol Sin. 2007 Dec;28(12):1968-74.

2. Wang H, Yang Y, Wang W, Guan B, Xun M, Zhang H, Wang Z, Zhao Y. Single-chain antibody-delivered Livin siRNA inhibits human malignant melanoma growth in vitro and in vivo. Tumour Biol. 2017 May;39(5):1010428317701645.

3. Wang H, Ran L, Hui K, Pei X, Wang X, Zheng Y. The inhibitor of apoptosis protein livin is upregulated in psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2018 Jun;32(6):e245-e247.

4. Wang H, Lei L, Hu J, Li Y. Oncostatin M upregulates Livin to promote keratinocyte proliferation and survival via ERK and STAT3 signalling pathways. Exp Physiol. 2020 Jul;105(7):1151-1158.

5. Wang H, Zhao W, Xu M, An L. Treatment of Keloids by Surgical Excision Combined With 5-Fluorouracil and Betamethasone Injection. Dermatol Surg. 2021 May 1;47(5):740-741.

Contact information

1. E-mail: wanghaonxyc@xjtu.edu.cn

2. Tel:

3. Home Page：

4. Address: No. 157, West 5th Road, Xi'an, China, Department of Dermatology, the Second Affiliated Hospital of Xi'an Jiaotong University